NYSE · HIMS
Hims & Hers Health, Inc.
Healthcare · Medical - Care Facilities
$27.68▼ 6.71% ($1.99)at close
After hours$27.67▼ 0.04%7:59 PM ET
Valuation
Revenue & margin DCF
A cash-flow estimate wouldn't be reliable here
Every projected year produces negative free cash flow, so the model returns a negative enterprise value. A discounted-cash-flow valuation cannot be defended on those inputs, so it is not shown.
- 10-yr revenue CAGR
- 19.6%
- Ending operating margin
- 0.0%
- Discount rate
- 13.1%
USD · TTM ending Jun 30, 2026 · Price used $27.68 · Price Oct 30, 8:00 PM UTC
What each scenario assumes. Click a column to start from it.
Price vs Fundamentals
Why The Stock Is Moving
What changed
The stock fell 37.18% over the last year. Revenue grew 28.04% over the trailing twelve months. Operating margin moved from 6.24% to -3.59%. Free cash flow declined 24.79% over the trailing twelve months.
What the market seems to be pricing
The stock has moved lower against modestly weakening underlying metrics. The operating data does not yet tell a clear story — the move may reflect sentiment, sector rotation, or macro factors rather than company-specific earnings power.
What would invalidate this read
Operating margin currently stands at -3.59%. A decisive move in revenue — currently up 28.04% — would be the clearest signal to resolve the ambiguity.
Return analysis
Company profile
Hims & Hers Health, Inc. operates a comprehensive digital health platform that seamlessly links individuals with licensed medical professionals for virtual consultations and ongoing care.
Market multiples
Stock splits
No stock splits recorded for this ticker.
Profitability & growth
Analyst consensus
7
Buy
13
Hold
0
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Actuals vs estimates by quarter, or any quarter against the same one a year earlier.
Next report
Nov 9, 2026
Q3 FY26 · EPS est $0.06 · Revenue est $892.9M
Same quarter, year over year
FY26 YTD -308.1%Each cell vs the same quarter a year earlier (the cell below) · Q1–Q2 combined -$0.77 vs $0.37 · 0 of 2 quarters up
Q1
Q2
Q3
Q4
FY total
FY26
—
—
FY25
FY24
FY23
—
—
—
Fiscal year totals
- FY25
- $0.50
- -7.4%
- FY24
- $0.54
- —
n/m: last year’s figure was zero, a loss or too small to compare against
Q2 FY26
Reported Aug 10, 2026 · Latest
HoverTap a cell to inspect
Actual
-$0.37
Estimate
-$0.05
Year over year
-317.6%
Vs prior quarter
n/m
Institutional Sentiment
Hims & Hers Health, Inc. · HIMS
From Form 13F filings (managers with $100M+). Filings land up to 45 days after quarter end — read this as positioning context, not live fund flow.